All Articles
-
2022
-
Better guidelines could help reduce racial disparities in clinical drug testing, physicians say
-
Triple Crises: COVID Pandemic, Mental Health, and Opioid Misuse
-
Buprenorphine induction via telemedicine during the pandemic
-
Changes in fentanyl positivity among medication for opioid use disorder (MOUD) patients
-
As COVID continued and the opioid epidemic worsened, 3 key health trends emerged in 2021
-
Greater naloxone availability, especially for fentanyl, could lower overdose deaths
-
Xylazine use is spreading, often with fentanyl
-
Update from the CDC: Gabapentin involvement in overdose deaths
-
New Draft CDC guidelines for opioid prescribing and monitoring
-
Illicitly manufactured fentanyls drove overdose deaths across the US in 2020
-
Physicians predict increased use of gabapentin for chronic pain
-
Physicians are confident in counseling, but consider drug testing critical to prevent misuse
-
Non-Small Cell Lung Cancer: Laboratory Testing for Diagnosis and Management
-
Breast Cancer: Screening and Early Diagnosis
-
Chronic Lymphocytic Leukemia: Diagnosis and Prognostic Markers
-
Women and Cardiovascular Disease: Risk Assessment
-
Tuberculosis: Laboratory Support of Screening and Diagnosis
-
Dementia and Alzheimer’s Disease: Laboratory Testing for Early Detection
-
Malignant Melanoma: Diagnosis, Laboratory Testing, and Management
-
Universal Chlamydia and Gonorrhea Screening in Young Women
-
New Guidelines for Assessing Chronic Kidney Disease
-
Apolipoprotein B and cardiovascular risk
-
2021
-
Stay-at-home orders increased overdose, research shows
-
Risk of prosecution for substance use during pregnancy
-
Presumptive and definitive testing: make the right choice by understanding the differences
-
Pharmacogenomics in mental health and addiction - Part 1: Genes and metabolism
-
Opioid use disorder increases the risks from COVID-19, especially for those not receiving medication-assisted treatment (MAT)
-
Opioid tapering increases the risk of overdose and mental health crisis
-
Drug Enforcement Agency (DEA) makes changes to prescribing rules during pandemic
-
Drug Enforcement Agency (DEA) plans to collect nationwide prescription data
-
Delta-8-THC: A new synthetic cannabinoid poses problems for testing
-
Full-Spectrum CBD May Trigger Positive THC Result
-
Genotyping and dose adjustment for chronic pain
-
Guidelines for tricyclic dosing based on pharmacogenomic testing
-
The “colliding pandemics” of COVID-19 and substance use disorder put patients at higher risk
-
Despite progress, over ½ of children tested in US have lead in blood
-
Blood lead declines, leading the CDC to change its reference value
-
Childhood blood lead levels have declined by 95% over the past 45 years
-
Emergency medical services encounters track rise in nonfatal overdoses
-
Has fentanyl mortality plateaued
-
Overdose Deaths from Fentanyl Rise Steadily
-
Chronic Kidney Disease: Laboratory Support of Diagnosis and Management
-
Chronic Kidney Disease: Laboratory Support of Diagnosis and Management
-
Colorectal Cancer Screening During the Pandemic
-
Melanoma: Early Detection and Challenges During the Pandemic
-
Lyme Disease: Laboratory Testing for Diagnosis
-
Hepatitis B: Laboratory Support of Diagnosis and Management
-
Multiple Myeloma: Laboratory Support of Diagnosis and Management
-
Cardiometabolic Disease
-
Breast Cancer: Current Disparities in Care
-
Insulin Resistance and the Evolution of Type 2 Diabetes
-
2020
-
The Prevalence and Danger of Drug Mixing
-
Treating and Protecting OUD Patients During Pandemic
-
Treating Mental Health and SUD Patients During Pandemic
-
Prescribing During the Pandemic
-
Pandemic Brings Drop in Testing, Increase in Illicit Drugs
-
Opioid Trends and Treatment During Pregnancy
-
Managing Chronic Pain During Pandemic
-
Impact of COVID-19 on Drug-Related Deaths
-
Getting Familiar with Kratom
-
Gabapentin Positivity Declined During the Pandemic
-
Drug Testing During Pregnancy
-
Demonstrating Kratom's Potential as Analgesic
-
COVID-19 and Substance Use Disorder
-
Combating Racial and Ethnic Behavioral Health Disparities During Pandemic
-
Microbes, Metals, and Mitragynine in Commercial Kratom Products
-
2019
-
Prescriber's Role in Preventing Prescription Drug Diversion
-
Presumptive Drug Testing: Rapid Results for Your Patient
-
Screening and Therapy Most Beneficial for OUD in Pregnant Women
-
The Importance of Definitive Drug Testing
-
What are the Signs of Opioid Use Disorder?
-
Don't Withhold MAT from Benzodiazepine Users, FDA Says
-
Drug Misuse in America 2019
-
Have Drug Overdose Death Totals Plateaued?
-
How Attitude and Language Affect Patients
-
How Words can Create or Avoid Stigma for Person with SUD
-
Importance of Baseline Drug Testing When Considering Opioid Therapy
-
Medication-Assisted Treatment for OUD
-
Medication-Based Treatment for OUD Effective Yet Underutilized
-
Naloxone Still Dramatically Underprescribed
-
New HHS Opioids Guide
-
2018 Opioid Bill: Increased Access to Treatment
-
AMA President Highlights Reduction in Stigma to Help End Opioid Crisis
-
Benzodiazepines: Primary Care's New Drug Problem
-
2018
-
2018 Quest Diagnostics Health Trends™ Report Now Available
-
House and Senate Prepare to Pass Bipartisan Bill to Fight Opioid Crisis
-
How Can Prescription Drug Monitoring Help Identify Abuse?
-
Keeping Patients Safe When Prescribing Opioids
-
Know Your Opioids
-
Opioid Epidemic Cost $504 Billion in 1 Year
-
2017
-
CDC Guidelines for Prescribing Opioids and Monitoring Use
-
Maine’s Diversion Alert Program Aids Physician Decision-Making
-
Number of Opioids Prescribed Has Fallen Since 2010
-
Opioids and Benzodiazepines Present Dangerous Combination
-
The Role of Urine Drug Testing in Pain Management
-
Updated Guidelines on Opioid Prescriptions and Testing
-
What a PDM Program Can Offer Your Practice
Your Privacy Choices